Quarterly Results

  • Company Name :
Lupin Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 500257
  • NSE Symbol:
  • LUPIN
  • P/E(TTM):
  • 17.59
  • ISIN Demat:
  • INE326A01037
  • Div & Yield%:
  • 0.59
  • EPS(TTM):
  • 115.47
  • Book Value(₹):
  • 531.54
  • Market Cap(₹Cr.):
  • 92,773.69
  • Face Value(₹):
  • 2.00
Quarters :  
Particulars June 2025 ( Cr)March 2025 ( Cr)December 2024 ( Cr)
Gross Sales 5,605.41 4,382.69 4,060.16
Excise Duty 0.00 0.00 0.00
Net Sales 5,605.41 4,382.69 4,060.16
Other Operating Income 103.18 102.98 147.84
Other Income 54.14 48.79 55.30
Total Income 5,762.73 4,534.46 4,263.30
Total Expenditure 2,978.95 2,739.54 2,874.17
PBIDT 2,783.78 1,794.92 1,389.13
Interest 18.90 33.85 19.55
PBDT 2,764.88 1,761.07 1,369.58
Depreciation 176.73 207.98 152.52
Tax 451.54 270.25 225.73
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 8.54 -8.51 6.66
Reported Profit After Tax 2,128.07 1,291.35 984.67
Extra-ordinary Items 0.00 0.00 -62.48
Adjusted Profit After Extra-ordinary item 2,128.07 1,291.35 1,047.15
EPS (Unit Curr.) 46.60 28.30 21.58
EPS (Adj) (Unit Curr.) 46.60 28.30 21.58
Calculated EPS (Unit Curr.) 46.59 28.28 21.58
Calculated EPS (Adj) (Unit Curr.) 46.59 28.28 21.58
Calculated EPS (Ann.) (Unit Curr.) 186.37 113.13 86.33
Calculated EPS (Adj) (Ann.) (Unit Curr.) 186.37 113.13 86.33
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 91.35 91.32 91.25
Reserve & Surplus 0.00 0.00 0.00
Face Value 2.00 2.00 2.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 49.66 40.95 34.21
PBDTM(%) 49.33 40.18 33.73
PATM(%) 37.96 29.46 24.25